Quijano, Mile Jhon .
HRN: 23-46-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2023
09/03/2023
IV
70mg
Q8h
Intra-abdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes